A detailed history of Barclays PLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Barclays PLC holds 147,827 shares of MGTX stock, worth $912,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,827
Previous 147,827 -0.0%
Holding current value
$912,092
Previous $618,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$3.88 - $5.23 $296,575 - $399,765
76,437 Added 107.07%
147,827 $618,000
Q2 2024

Aug 14, 2024

SELL
$4.21 - $5.81 $22,603 - $31,193
-5,369 Reduced 6.99%
71,390 $300,000
Q1 2024

May 15, 2024

SELL
$5.78 - $7.33 $126,541 - $160,475
-21,893 Reduced 22.19%
76,759 $465,000
Q4 2023

Feb 15, 2024

BUY
$3.6 - $7.15 $112,741 - $223,916
31,317 Added 46.51%
98,652 $693,000
Q3 2023

Nov 07, 2023

SELL
$4.79 - $7.19 $3,530 - $5,299
-737 Reduced 1.08%
67,335 $331,000
Q2 2023

Aug 03, 2023

SELL
$5.19 - $8.07 $74,902 - $116,466
-14,432 Reduced 17.49%
68,072 $457,000
Q1 2023

May 04, 2023

BUY
$5.04 - $8.6 $43,182 - $73,684
8,568 Added 11.59%
82,504 $426,000
Q4 2022

Feb 13, 2023

BUY
$5.8 - $8.98 $151,275 - $234,216
26,082 Added 54.5%
73,936 $482,000
Q3 2022

Nov 03, 2022

SELL
$7.55 - $11.25 $1,781 - $2,655
-236 Reduced 0.49%
47,854 $403,000
Q2 2022

Aug 12, 2022

BUY
$6.8 - $14.23 $44,723 - $93,590
6,577 Added 15.84%
48,090 $364,000
Q1 2022

May 16, 2022

SELL
$13.42 - $23.38 $238,943 - $416,280
-17,805 Reduced 30.02%
41,513 $575,000
Q4 2021

Feb 14, 2022

BUY
$12.78 - $23.74 $10,390 - $19,300
813 Added 1.39%
59,318 $1.41 Million
Q3 2021

Nov 09, 2021

BUY
$11.73 - $16.08 $97,910 - $134,219
8,347 Added 16.64%
58,505 $772,000
Q2 2021

Aug 13, 2021

SELL
$12.85 - $16.2 $54,188 - $68,315
-4,217 Reduced 7.76%
50,158 $778,000
Q1 2021

May 13, 2021

BUY
$13.84 - $17.8 $134,414 - $172,873
9,712 Added 21.75%
54,375 $785,000
Q4 2020

Feb 11, 2021

BUY
$12.4 - $17.6 $298,282 - $423,368
24,055 Added 116.73%
44,663 $676,000
Q3 2020

Nov 12, 2020

SELL
$11.59 - $14.93 $21,731 - $27,993
-1,875 Reduced 8.34%
20,608 $274,000
Q2 2020

Aug 12, 2020

BUY
$11.79 - $15.97 $162,926 - $220,689
13,819 Added 159.5%
22,483 $283,000
Q1 2020

May 13, 2020

SELL
$9.31 - $21.24 $80,242 - $183,067
-8,619 Reduced 49.87%
8,664 $117,000
Q4 2019

Feb 10, 2020

BUY
$13.91 - $21.48 $1,613 - $2,491
116 Added 0.68%
17,283 $346,000
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $633 - $1,200
40 Added 0.23%
17,167 $274,000
Q2 2019

Aug 14, 2019

BUY
$17.38 - $26.88 $162,155 - $250,790
9,330 Added 119.66%
17,127 $461,000
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $71,732 - $165,374
7,797 New
7,797 $135,000
Q4 2018

Feb 14, 2019

SELL
$9.61 - $14.02 $13,309 - $19,417
-1,385 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$8.1 - $13.6 $11,218 - $18,836
1,385 New
1,385 $19,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $278M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.